Christoph MassnerinEarlybird's viewWill psychedelics revolutionize mental health treatment?5 ways psychedelics research and investment are evolving7 min read·Jun 29, 2022----
Christoph MassnerinEarlybird's viewMiracor Medical is our second portfolio company to receive Breakthrough Device Designation from the…Earlybird is pleased to announce that Miracor Medical, based in Belgium, is our second portfolio company to receive Breakthrough Device…4 min read·Aug 22, 2019----